Diagnosis has traditionally been overshadowed by new drug discoveries. But the expansion of molecular diagnostics is creating new careers for researchers in many fields. Hannah Hoag reports.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hoag, H. Testing new ground. Nature 429, 682–683 (2004). https://doi.org/10.1038/nj6992-682a
Issue Date:
DOI: https://doi.org/10.1038/nj6992-682a
This article is cited by
-
Diagnostics and biomarker development: priming the pipeline
Nature Reviews Drug Discovery (2006)